0.6753
Nexgel Inc stock is traded at $0.6753, with a volume of 124.81K.
It is down -0.97% in the last 24 hours and down -39.16% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.6819
Open:
$0.7037
24h Volume:
124.81K
Relative Volume:
0.52
Market Cap:
$5.50M
Revenue:
$11.67M
Net Income/Loss:
$-2.79M
P/E Ratio:
-1.7851
EPS:
-0.3783
Net Cash Flow:
$-2.55M
1W Performance:
-16.06%
1M Performance:
-39.16%
6M Performance:
-71.86%
1Y Performance:
-77.71%
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
NXGL
Nexgel Inc
|
0.6753 | 5.55M | 11.67M | -2.79M | -2.55M | -0.3783 |
|
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc Stock (NXGL) Latest News
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com
NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Oxford Industries Earnings: What To Look For From OXM - Barchart.com
NEXGEL secures $1.8 million financing for potential acquisition - MSN
NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo
Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn
Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn
NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo
NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World
NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria
UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com
NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com
NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView
NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative
NEXGEL Signs Definitive Agreement to License and Acquire - GlobeNewswire
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga
2 Reasons to Like CALM (and 1 Not So Much) - Barchart.com
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com
NEXGEL CEO Adam Levy to Join 6th Annual Semco Capital Networking Event in Chicago - MSN
Is NEXGEL Inc. Equity Warrant stock resilient to inflationWeekly Trade Summary & Weekly High Return Opportunities - Naître et grandir
NEXGEL Expands Partnership With STADA, Secures $1 Million to Fuel New Product Launches - MSN
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.04 - Markets Mojo
Stocks in play: Quarterhill Inc. - Barchart
Head to Head Survey: Pacific Biosciences of California (NASDAQ:PACB) and NexGel (NASDAQ:NXGL) - Defense World
NexGel, Inc. Hits New 52-Week Low at $1.05 Amidst Decline - Markets Mojo
NexGel, Inc. Stock Plummets to New 52-Week Low of $1.09 - Markets Mojo
NXGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
NXGL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
NexGel, Inc. Hits New 52-Week Low at USD 1.15 Amid Decline - Markets Mojo
NexGel, Inc. Hits New 52-Week Low at $1.11 Amidst Declining Performance - Markets Mojo
NXGLW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Earnings Report: Is NEXGEL Inc currently under institutional pressureRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):